Business  
/
 
Sectors  
/
 
Health & Pharma
The fall in Chinese sales, described by Deutsche Bank analysts as “dire”, was steeper than investors expected and Witty told reporters it was too early to say when business might recover from the Chinese-government probe into allegations that GSK had bribed doctors to boost drug sales. Photograph: Reuters/Toby Melville Bribery scandal slashes GlaxoSmithKline’s Chinese drug sales

China sales slump 61% as doctors shun GSK products

Irish MEP Nessa Childers: recent controversies such as the PIP breast implants “which affected thousands of women in Ireland and across the EU in 2012”, were reminders of the need for regulations covering manufacturing quality EU parliament agrees new rules on medical devices

Patients should have an ‘implant card’ and be given access to ‘track records’ of devices

EU’s medical devices directive is one the industry in Ireland is going to keep within its sights over the next few months Lobby groups at the ready over key directive

On the one hand, the new medical devices directive is responding to public concerns about patient safety. On the other side industry is staunchly opposed to new rules

Asia Briefing: Canton Fair battles yuan’s strength

Asia Briefing: Pharma GSK gets no relief from China woes

Representatives of the Irish medical devices industry, which employs about 25,000 people, have argued that the new rules could threaten the industry here. Representatives of the Irish medical devices industry, which employs about 25,000 people, have argued that the new rules could threaten the industry here. MEPs focus on rules for medical devices

Debate today on amendments to controversial directive ahead of key vote

Byrne Looby Partners, which worked on the Aviva Stadium project in Dublin, is to create 25 jobs at its Irish offices and a further 25 overseas. University of Limerick, Alltech and Byrne Looby Partners announce 340 new jobs

Bernal Project at UL to create 220 positions

Ronan O’Caoimh, chief executive officer of Trinity Biotech. Photograph: Alan Betson Revenues up at Trinity Biotech

Nasdaq-listed company in blood bank business acquisition

Swiss group Roche yesterday posted an 8 per cent rise in third-quarter sales in local currencies, helped by strong uptake of two new breast cancer drugs. Photograph: AP Photo Roche boosted by strong drug sales in US and China

World’s largest maker of cancer drugs chalked up growth of 12 per cent in the US in first nine months of the year

Amarin shares slump on FDA panel rejection

Company fails to persuade advisory panel to back exponential expansion of market for cardiovascular drug

Amarin fails to secure backing of FDA panel for expanded use

FDA is scheduled to decide whether to clear the drug for wider use by December 20th

Lower taxes and cost-cutting also helped Abbott beat earnings forecasts, analysts said. The company’s shares jumped 4.5 per cent in early trading to $35.23. Photographer: Tim Boyle/Bloomberg Abbott beats profit forecasts, raises dividend sharply

Strong demand for diagnostics offsets weakness in nutritionals as prices are dropped in face of Chinese price-fixing investigation

Cantillon: Amarin tests FDA appetite for fish oil drug

Stock value suggests even its proponents are not entirely sure of their ground

Many of Roche’s most promising medicines, such as rheumatoid arthritis treatment RoActemra and new breast cancer drugs Kadcyla and Perjeta are biologics, which unlike chemical drugs are proteins or cells derived from living organisms that are hard to replicate. Photograph: Keystone, Gaetan Bally Roche to spend $880m on manufacturing, creating 500 jobs

Expansion shows Roche’s confidence in its development pipeline of new cancer drugs

A worker outside a Merck facility in New Jersey, US, yesterday. The drugmaker will eliminate 8,500 of its 81,000 global workforce in its latest revamp. Photograph: Emile Wamsteker/Bloomberg Merck to slash budget to boost earnings

Research and jobs targeted in massive cuts

Perrigo is set to acquire Elan in a $8.6 billion (€ 6.48 billion) deal Elan shareholders to vote on deal

Shareholders to vote on proposed New Perrigo acquisiton on November 18th

Small advanced nations have different policy considerations to large nations and therefore may have different areas of focus,” said Science Foundation Ireland director general Prof Mark Ferguson, who is also chief scientific adviser to the Government. Six Nations in Dublin for science conference

Event culminates with Global Irish Economic Forum at Farmleigh

“We are very excited about the new facility in Bray, and we are keen to make sure the local economy really benefits from the positions that we will be interviewing for over the coming weeks,” said Brian McMahon, a director of McMahon Healthcare. McMahon group to open second nursing home

Opening will create 120 jobs in Bray over the next three months

Most Read in Business

1 Facebook doubles office space in Dublin
2 Bank of Ireland agrees deal to cut pension deficit
3 Willingness, not affordability, the crux for America’s economy
4 Building a silicon valley in the Italian Alps
5 Court appoints interim examiner to Siac

Latest Business

20:39 Stocks led down by weakness in banking sector as detail emerged of stress tests to be led by the ECB
19:23 Court appoints interim examiner to Siac
16:58 Boeing beats analysts’ estimates with an increase in jetliner deliveries
16:52 Exercise, eat, sleep . . . and share?
16:51 Central bank issues warning on unauthorised investment firm

Columnists

Martin Wolf Martin Wolf -

Willingness, not affordability, the crux for America’s economy

Ciarán Hancock Ciarán Hancock - Business Affairs Correspondent

Why ‘aeroholic’ Buffett avoids buses with wings

Opinion & Analysis

New lottery operator gambles on online sales and technology
EU’s medical devices directive is one the industry in Ireland is going to keep within its sights over the next few months Lobby groups at the ready over key directive
Apple still finds itself in the driving seat of a product segment it has effectively pioneered. And that’s why the public – and the media – pays so much attention to Apple events. Photograph: Simon Dawson/Bloomberg Cantillon: Apple hype-machine in overdrive

Markets

Ernst & Young entrepreneur of the year
Entrepreneur of the Year 24 businesses are shortlisted for Ernst & Young awards
 

Facebook

epaper_300x120
pagesales_300x120